2022 annual financial data
TG Therapeutics 2022 Net margin
Direct answer
Net margin was -8,036.34%.
Operating income was -218,316,000 USD and net income was -223,812,000 USD.
Operating cash flow was -176,170,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,785,000 USD
- Operating income
- -218,316,000 USD
- Net income
- -223,812,000 USD
- Operating cash flow
- -176,170,000 USD